Zen Multi-Specialty Hospital, Chembur, has been recognized by the Asia Book of Records for hosting a record-setting live laparoscopic surgery broadcast known as 'Laparoscopy Unlimited' with a total participation of 2635 medical professionals plus...
The Coalition for Epidemic Preparedness Innovations (CEPI) has partnered with the Serum Institute of India (SII) Pvt. Ltd. the world’s largest vaccine manufacturer and part of the Cyrus Poonawalla Group to strengthen global pandemic preparedness
In a significant public health milestone, the World Health Organization (WHO) has recognized the Maldives for successfully eliminating mother-to-child transmission (EMTCT) of hepatitis B, while also upholding its previous validation (in 2019) for EMT
Pfizer Inc. will be presenting the latest developments of their infectious disease portfolio at IDWeek 2025 from October 19-22, 2025.
Bristol Myers Squibb (BMS) has made it clear that he is bringing Kopozgo (Mavacamten) to the Indian market. This is the first and only oral, selective cardiac myosin inhibitor for New York Heart Association (NYHA) Class II–III
Aurobindo Pharma's promoter group has successfully secured around 2,000 crore with a dual-tranche financing structure intended for platform acquisitions, which includes the Taj Banjara asset situated in Hyderabad. The funds are being directed
Cadila Pharmaceuticals, one of the leading research-based pharmaceutical companies in India, has now launched Dlorfast-M Tablets. It is a new fixed-dose combination tablet that contains 5 mg of Desloratadine (a novel antihistamine) and 10 mg...
Hikal Ltd., a long-term reliable partner to top global life sciences companies, has opened its state-of-the-art High Potency Active Pharmaceutical Ingredient (HPAPI) Laboratory at the Integrated Innovation Centre in Pune.
In a significant regulatory action against substandard goods, the Government of India has made an immediate announcement and imposed price-based import restrictions on substandard Sulfadiazine API. This speculation comes with an effective date...
Eli Lilly today announced it will present clinical data on Verzenio and multiple novel pipeline updates at the 2025 ESMO Annual Meeting in Berlin from October 17-21. The new data includes updates from across Lilly’s oncology portfolio as...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")